RecruitingNot ApplicableNCT06719739

Functional IOL Implantation in Patients With Epiretinal Membrane

Clinical Outcomes in Cataract Patients With Macular Epiretinal Membrane After Implantation of Functional Intraocular Lenses

Sponsor

Eye & ENT Hospital of Fudan University

Enrollment

90 participants

Start Date

Sep 21, 2024

Study Type

INTERVENTIONAL

Conditions

Epiretinal Membrane Cataract Intraocular Lens Complication

Summary

We have designed this prospective study to evaluate macular involvement and epiretinal membrane (ERM) grading by OCT in eyes with ERM and to compare clinical outcomes after implantation of Enhance IOL with standard monofocal IOL in eyes with ERM grading preoperatively, aiming to find out whether functional IOL is benefit for patients with ERM.

Eligibility

Min Age: 20 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Intraocular lens implantation for people with cataract, epiretinal membrane, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 20 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEIntraocular lens implantation

Cataract patients scheduled for surgery will be evaluated by OCT, and those diagnosed with macular epiretinal membrane will be implanted in different IOLs according to the patients' decision: monodical IOL or functional IOL.